Predictive Biosciences Announces Next-Generation Sequencing Assay for p53
Published: Friday, December 07, 2012 Last Updated: Friday, December 07, 2012
Predictive Biosciences announced it has developed a new next-generation sequencing (NGS) assay for the TP53 gene (encoding the p53 protein) that will enhance the clinical performance of its bladder cancer assay.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.